Dr. Jonathan C. King

Nicholas Nissen is a General Surgeon and a Transplant Surgeon in West Hollywood, California. Dr. Nissen is rated as an Elite provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Liver Transplant, and Pancreatectomy.

Timothy Donahue is a General Surgeon and a Surgical Oncologist in Los Angeles, California. Dr. Donahue is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

A talented surgeon and award-winning instructor and researcher, Laleh G. Melstrom, M.D., M.S., joined City of Hope, attracted by the opportunity to help develop breakthrough cures and treatments. Educated at Johns Hopkins University, Dr. Melstrom received her medical degree at Cornell Medical College in New York City, continuing her training at Northwestern Memorial Hospital in Chicago and New York's Memorial Sloan-Kettering Cancer Center. She held professorships at both Cornell and Robert Wood Johnson Medical School, before arriving in California. Dr Melstrom is certified in robotic surgery and specializes in the treatment of cancers of the liver, pancreas, melanoma and sarcoma. She has published over 120 scholarly articles and is a sought-after speaker at national and international conferences. Expertise: Liver Cancer, Pancreas Cancer, Metastatic Colon or Rectal Cancer to Liver, Hepatic Artery Infusion Pump, Cholangiocarcinoma, Neuroendocrine Tumors, Gallbladder Cancer, Melanoma, Sarcomas, Robotic SurgeryResearch Areas: Metastatic CRC, Melanoma, Bile Duct Cancer, Liver Cancer. Dr. Melstrom is rated as a Distinguished provider by MediFind in the treatment of Metastatic Insulinoma. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection.